BioSpace News Archive

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has selected 3 of its clinical sites for its Phase 2a clinical trial for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

Today, Cardinal Health (NYSE: CAH) published its Fiscal 2022 Environmental, Social and Governance (ESG) Report, which demonstrates the company’s actions to reduce its environmental impact, create a world-class work culture, better serve customers, and strengthen the communities where employees live and where the company does business.

Phio Pharmaceuticals Corp. today announced that the Company’s Board of Directors has approved a reverse stock split of its shares of common stock.

Inhibikase Therapeutics, Inc. today announced the publication of studies describing the potential of IkT-148009 as a disease-modifying therapy for Parkinson’s disease and related disorders.

Crown Bioscience , a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.

Zymeworks Inc. today announced that management will participate in the following upcoming investor conferences.

Atomic AI launched today with a $35 million Series A round led by Playground Global, with participation from 8VC, Factory HQ, Greylock, NotBoring, AME Cloud Ventures, and renowned angel investors including GitHub ex-CEO Nat Friedman, Doug Mohr, Curai CEO Neal Khosla, and UC Berkeley professor and Arc Institute Co-founder Patrick Hsu.

180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced the publication of a review entitled ‘ Treatments for early stage Dupuytren’s disease: an evidence-based approach ’ in The Journal of Hand Surgery (European Volume).

Flipt, a healthcare technology and services company that offers a new approach to pharmacy care focused on improving pricing and patient access for prescription medications, announced today that it has entered into a multi-year services agreement with Evio Pharmacy Solutions.

ALERCELL, INC. announced today that it has launched a new website LENA DIAGNOSTICS ©" www.lenadx.com.